Defense Health Research Consortium to Congress: Enact the Fiscal Year 2021 Defense Appropriations Act
The Defense Health Research Consortium (DHRC) and dozens of its affiliated members recently sent a letter to House and Senate leadership, calling on them “to work toward the enactment of the fiscal year 2021 Defense Appropriations Act, to ensure that the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs (CDMRP), are fully funded in fiscal year 2021.”
The letter, signed by 104 patient advocacy organizations, health and medical associations, veterans organizations and colleges and universities, warns of the consequences of enacting a long-term continuing resolution in lieu of a fully-funded Defense Appropriations Act. According to the letter “under a year-long continuing resolution the CDMRP would receive no funding in fiscal year 2021. Failure to enact the Defense Appropriations Act will have major negative health implications for the millions of Americans – especially veterans, military service members and their families – who live with chronic and debilitating disorders.”
The Defense Health Research Consortium was founded by CRD Associates to bring a diverse community together to advocate for the CDMRP, a $1.2 billion medical research program designed to meet the unique health and medical challenges of the men and women in the U.S. Armed Services. Funding for the CDMRP is added every year by Congress to the annual Defense Appropriations Act, and this funding has faced threats and similar challenges in previous years.